Effectiveness and safety of intragastric balloon for treatment of morbid obesity

To evaluate the effectiveness and safety of intragastric balloon (IGB) for the treatment of obese Chinese. IGB was placed into the stomachs of 48 Chinese patients in Hong Kong, 13 males and 35 females; aged 39 +/- 9 (18 - 65), with the mean baseline body weight (BW) of 106 +/- 26 kg and mean body ma...

Full description

Saved in:
Bibliographic Details
Published inZhong hua yi xue za zhi Vol. 87; no. 6; p. 388
Main Authors Mui, Wilfred Lik-Man, Ng, Enders Kwok-Wai, Tsung, Bonnie Yuk-San, Wang, Rui-Zhi, Cheng, Angela Yuen-Shan, Yau, Phyllis Yin-Ping, Lam, Chuen-Hing, Chow, Francis Chun-Chung
Format Journal Article
LanguageChinese
Published China 06.02.2007
Subjects
Adult
Body Mass Index
Body Weight
Diet, Reducing
Exercise
Female
Follow-Up Studies
Gastric Balloon
Hong Kong
Humans
Male
Middle Aged
Obesity, Morbid - therapy
Treatment Outcome
Hong Kong
Online AccessGet more information

Cover

More Information
Summary:To evaluate the effectiveness and safety of intragastric balloon (IGB) for the treatment of obese Chinese. IGB was placed into the stomachs of 48 Chinese patients in Hong Kong, 13 males and 35 females; aged 39 +/- 9 (18 - 65), with the mean baseline body weight (BW) of 106 +/- 26 kg and mean body mass index (BMI) of (40 +/- 9) kg/m(2), 34 (70.8%) with coexistent obesity-related morbidities, who failed to respond to other weight reducing treatment, via routine gastroscopy under intravenous conscious sedation. Restricted balanced diet with 1200 kcal/day and exercise of 150 minutes/week were prescribed after the balloon placement. The IGB was removed endoscopically after at most 180 days. Follow-up was conducted once a week during the first month and then once a month. The median hospital stay and treatment duration were 1 (IQR 1:2.25) day and 174 (IQR 166:181) days respectively. The BW, BMI, and waist circumference were significantly decreased after the IGB placement (all P < 0.01) with the mean BW loss of (13
ISSN:0376-2491